UNITY
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of aging-related diseases... Read moreUNITY
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of aging-related diseases... Read more
News
May 07, 2025
People Matters
UNITY: This firm lays off every single employee, including CEO Anirvan Ghosh
May 05, 2025
centralcharts
Press Release: UNITY : UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
May 05, 2025
SFGate
UNITY: Bay Area biotech company Unity, once worth $700M, lays off entire remaining workforce
May 05, 2025
Endpoints News
UNITY: Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year
May 01, 2025
Benzinga
UNITY: UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
Apr 23, 2025
GlobalNewswire
Press Release: UNITY : UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
Apr 22, 2025
Marketscreener
UNITY: Unity Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
Mar 25, 2025
Clinical Trials Arena
UNITY: Unity reports topline outcomes from trial of diabetic macular oedema therapy
Mar 25, 2025
BioSpace
UNITY: Opthea, UNITY Fail to Unseat Regeneron's Eylea in Vision Disorders
Mar 25, 2025
Zacks
UNITY: UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study
UNITY Competitors
1
2
3
4
5